id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2647784,a3f4e0cb-2d1c-45eb-8802-b2ae40aeddd2,Q2,ISEMAN & ASSOCIATES LLC,401103582,"TICHENOR VENTURES, LLC",2021,second_quarter,PHA,Monitoring biotech legislation; prescription drug prices,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2021-07-19T15:06:36.883000-04:00
2647785,a3f4e0cb-2d1c-45eb-8802-b2ae40aeddd2,Q2,ISEMAN & ASSOCIATES LLC,401103582,"TICHENOR VENTURES, LLC",2021,second_quarter,MED,Monitoring biotech legislation,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2021-07-19T15:06:36.883000-04:00
2647786,a3f4e0cb-2d1c-45eb-8802-b2ae40aeddd2,Q2,ISEMAN & ASSOCIATES LLC,401103582,"TICHENOR VENTURES, LLC",2021,second_quarter,BUD,COVID-19 relief/recovery legislation,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2021-07-19T15:06:36.883000-04:00
2647787,a3f4e0cb-2d1c-45eb-8802-b2ae40aeddd2,Q2,ISEMAN & ASSOCIATES LLC,401103582,"TICHENOR VENTURES, LLC",2021,second_quarter,AVI,Monitoring the FAA Reauthorization Act,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2021-07-19T15:06:36.883000-04:00